Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.3 USD | +1.47% | +3.61% | +13.16% |
10/06 | PolyPid Ltd. to Provide an Update on the Ongoing D-Plex100 Phase 3 Trial | CI |
08/05 | Transcript : PolyPid Ltd., Q1 2024 Earnings Call, May 08, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+13.16% | 20.63M | |
+51.54% | 795B | |
-7.20% | 350B | |
+18.67% | 328B | |
+7.48% | 294B | |
+17.58% | 245B | |
+0.98% | 222B | |
+10.88% | 215B | |
+3.64% | 160B | |
-3.96% | 157B |
- Stock Market
- Equities
- PYPD Stock
- News PolyPid Ltd.
- PolyPid Says FDA Schedules Type D Meeting to Discuss Late-Stage Study, Regulatory Pathway for D-Plex100